The decrease in the PMN count represents a sign of improvement, due to the regulating and anti-inflammatory effect of the medication Rhemacell 2 G.
The improvement in the clinical symptoms evidences a clear stabilising and stimulating effect of the repair of the joint tissue.
More Information |
||
| » Rhemacell 2G » Clinical Information and Pharmacology » Mechanisms of Action » Pharmacokinetics |
» Indications » Contraindications » Toxicity » Clinical Studies |
» Conclusions
» Material and Methods » References |


